Product
Supplier
Encyclopedia
Inquiry
Cagrilintide buy - large image1
Cagrilintide buy - image1

Cagrilintide

66 Inquiries

Unit Price: Get Latest Price
CAS No.:

1415456-99-3

Content:

99%

Brand:

CUIKANG

Packaging:

G/bottle,Kg/bag,25kg/barrel

Sample Available:

Yes

Price valid (until):

2025-01-30

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
45 days
Qualification:
Main Products:

Cosmetics raw materials,Pesticide intermediate,Photoelectric material,pharmaceutical intermediates,Raw materials for food and health products,Polymer materials

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Cagrilintide is a novel, long-acting amylin analogue. As a non-selective amylin receptor (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist, Cagrilintide has important application prospects in the medical field

    Items Specifications






    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    ‌Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide

    CAS No.:

    1415456-99-3

    Molecular Formula:

    C194H312N54O59S2

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Cosmetics raw materials,Pesticide intermediate,Photoelectric material,pharmaceutical intermediates,Raw materials for food and health products,Polymer materials

    Location:

    D307, Zhuque Square Office Building, No. 14, Chang'an North Road, Beilin District, Xi'an City, Shaanxi Province

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    45 days

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    Company Certificates
    • Shaanxi Cuikang Pharmaceutical TechnologISO ISO
    • Shaanxi Cuikang Pharmaceutical TechnologISO ISO
    • Shaanxi Cuikang Pharmaceutical TechnologISO ISO

    Shaanxi Cuikang Pharmaceutical Technology Co., Ltd., founded in January 2023, is a wholly-owned subsidiary of Shaanxi Cuicheng Bio-pharmaceutical Technology Co., Ltd., and a comprehensive innovative enterprise focusing on the research and development, production, sales, import and export trade, technical services and related resource allocation and integration of products in the field of fine chemistry and biochemistry. The company has built a 2700 square meter R&D center in Hanzhong, Shaanxi Province, and has established in-depth and stable cooperative relations with three factories, which can provide one-stop service for domestic and foreign customers from pilot R&D to industrial scale-up production.

    Cuikang Company is an enterprise integrating natural products, fine chemicals, biological fermentation, innovative material research and development, production, sales and technical services. It can provide global customers with a series of products with different specifications and models, such as proportional plant extracts, content plant extracts, synthetic chemical blocks, synthetic pharmaceutical intermediates, active API molecules, fermented pharmaceutical intermediates and APIs, health food, functional food raw materials, veterinary drug raw materials, pharmaceutical innovative materials, laboratory equipment, pharmaceutical machinery and equipment.

    The company adheres to the market demand-oriented, technical innovation as the starting point, product quality as the core, customer service as the foundation, and the enterprise spirit of "professional integrity", and wholeheartedly provides high-quality products and services for customers at home and abroad.


  • Inquiry History
    66 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrilintide

    10 MG Sep 23, 2026
    United States

    Cagrilintide

    25 MG Aug 31, 2026
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Hongkong, China

    Cagrilintide

    100 MG Apr 22, 2026
    United Kingdom

    Cagrilintide

    1 KG Apr 14, 2026
    Ireland

    Cagrilintide

    10 PCS Apr 14, 2026
    United States

    Cargrilintide

    10 MG Mar 19, 2026
    United Kingdom

    cagrilintide

    10 MG Feb 18, 2026
    China

    CagriSema cagrilintide 2.5mg+Samaglutide2.5mg

    10 MG Jan 26, 2026
    South Korea

    Cagrilintide

    500 MG Jan 21, 2026
    Pakistan

    cagrilintide

    1 KG Dec 26, 2025
    United States

    Cagrilintide

    20 MG Dec 19, 2025
    United Kingdom

    Cagrilintide

    100 MG Dec 10, 2025
    Canada

    All peptides

    1001 MT Nov 12, 2025
    United States

    Cagrilintide

    10 MG Oct 13, 2024
    United States

    Cagrilintide

    1 MG Jun 3, 2024
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.